LiveASX is an independent website and is not affiliated with, endorsed by, or associated with ASX Limited.

IMMURON LIMITED (IMC)

Health care · Historical news and closing prices

Immuron Reports Quarterly Sales Growth And Cuts ATM Facility Capacity

IMC · Health care · 2026-10-27

Immuron reported quarterly sales of approximately A$2 million, up 9% on the prior-year period and 5% on the previous quarter, with Australian and Canadian sales rising while US sales declined. The company attributed Australian growth partly to Travelan’s relaunch and said US inventory has been replenished after customs and logistics delays. Separately, Immuron reduced the capacity of its existing at-the-market funding facility to approximately US$2 million, retaining discretion over whether and when to issue shares.

Closing price · 2026-10-27: $0.037 · -7.50%